MPWT
PYXS icon

MassMutual Private Wealth & Trust’s Pyxis Oncology PYXS Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio PYXS Stock Details PYXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-133
Closed -$1K – 1674
2022
Q1 		$1K Buy
+133
New +$972 ﹤0.01% 1400

Other funds holding PYXS

LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return

MassMutual Private Wealth & Trust's PYXS Position: Q2 2022 in Review

MassMutual Private Wealth & Trust sold out of Pyxis Oncology (PYXS) in Q2 2022, closing a stake of 133 shares — an estimated $1K sold.

MassMutual Private Wealth & Trust first reported a position in PYXS in Q1 2022 and held it in 1 quarter. The position peaked at $1K in Q1 2022. 39 funds tracked by Wall St. Rank hold PYXS as of Q2 2022.

  • MassMutual Private Wealth & Trust reported no remaining Pyxis Oncology position as of Q2 2022 after selling out during the quarter.
  • MassMutual Private Wealth & Trust sold 133 Pyxis Oncology shares in Q2 2022, an estimated $1K.
  • MassMutual Private Wealth & Trust first reported a position in Pyxis Oncology in Q1 2022 and held it in 1 quarter.
  • MassMutual Private Wealth & Trust's Pyxis Oncology position peaked at $1K in Q1 2022.
  • 39 funds tracked by Wall St. Rank held Pyxis Oncology as of Q2 2022.

Based on MassMutual Private Wealth & Trust's 13F filing for Q2 2022, filed 7 Jul 2022.